Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice

Ryoji Ito, Takeshi Takahashi, Ikumi Katano, Kenji Kawai, Tsutomu Kamisako, Tomoyuki Ogura, Miyuki Ida-Tanaka, Hiroshi Suemizu, Satoshi Nunomura, Chisei Ra, Akio Mori, Sadakazu Aiso, Mamoru Ito

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The development of animal models that mimic human allergic responses is crucial to study the pathophysiology of disease and to generate new therapeutic methodologies. Humanized mice reconstituted with human immune systems are essential to study human immune reactions in vivo and are expected to be useful for studying human allergies. However, application of this technology to the study of human allergies has been limited, largely because of the poor development of human myeloid cells, especially granulocytes and mast cells, which are responsible for mediating allergic diseases, in conventional humanized mice. In this study, we developed a novel transgenic (Tg) strain, NOD/Shi-scid-IL2rgnull (NOG), bearing human IL-3 and GM-CSF genes (NOG IL-3/GM-Tg). In this strain, a large number of human myeloid cells of various lineages developed after transplantation of human CD34+ hematopoietic stem cells. Notably, mature basophils and mast cells expressing FcRI were markedly increased. These humanized NOG IL-3/GM-Tg mice developed passive cutaneous anaphylaxis reactions when administered anti-4-hydroxy-3- nitrophenylacetyl IgE Abs and 4-hydroxy-3-nitrophenylacetyl. More importantly, a combination of serum from Japanese cedar pollinosis patients and cedar pollen extract also elicited strong passive cutaneous anaphylaxis responses in mice. Thus, to our knowledge, our NOG IL-3/ GM-Tg mice are the first humanized mouse model to enable the study of human allergic responses in vivo and are excellent tools for preclinical studies of allergic diseases.

Original languageEnglish
Pages (from-to)2890-2899
Number of pages10
JournalJournal of Immunology
Volume191
Issue number6
DOIs
Publication statusPublished - 2013 Sep 15
Externally publishedYes

ASJC Scopus subject areas

  • Immunology

Cite this

Ito, R., Takahashi, T., Katano, I., Kawai, K., Kamisako, T., Ogura, T., ... Ito, M. (2013). Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice. Journal of Immunology, 191(6), 2890-2899. https://doi.org/10.4049/jimmunol.1203543

Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice. / Ito, Ryoji; Takahashi, Takeshi; Katano, Ikumi; Kawai, Kenji; Kamisako, Tsutomu; Ogura, Tomoyuki; Ida-Tanaka, Miyuki; Suemizu, Hiroshi; Nunomura, Satoshi; Ra, Chisei; Mori, Akio; Aiso, Sadakazu; Ito, Mamoru.

In: Journal of Immunology, Vol. 191, No. 6, 15.09.2013, p. 2890-2899.

Research output: Contribution to journalArticle

Ito, R, Takahashi, T, Katano, I, Kawai, K, Kamisako, T, Ogura, T, Ida-Tanaka, M, Suemizu, H, Nunomura, S, Ra, C, Mori, A, Aiso, S & Ito, M 2013, 'Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice', Journal of Immunology, vol. 191, no. 6, pp. 2890-2899. https://doi.org/10.4049/jimmunol.1203543
Ito R, Takahashi T, Katano I, Kawai K, Kamisako T, Ogura T et al. Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice. Journal of Immunology. 2013 Sep 15;191(6):2890-2899. https://doi.org/10.4049/jimmunol.1203543
Ito, Ryoji ; Takahashi, Takeshi ; Katano, Ikumi ; Kawai, Kenji ; Kamisako, Tsutomu ; Ogura, Tomoyuki ; Ida-Tanaka, Miyuki ; Suemizu, Hiroshi ; Nunomura, Satoshi ; Ra, Chisei ; Mori, Akio ; Aiso, Sadakazu ; Ito, Mamoru. / Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice. In: Journal of Immunology. 2013 ; Vol. 191, No. 6. pp. 2890-2899.
@article{7229cd321647439e9b728967e9abede9,
title = "Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice",
abstract = "The development of animal models that mimic human allergic responses is crucial to study the pathophysiology of disease and to generate new therapeutic methodologies. Humanized mice reconstituted with human immune systems are essential to study human immune reactions in vivo and are expected to be useful for studying human allergies. However, application of this technology to the study of human allergies has been limited, largely because of the poor development of human myeloid cells, especially granulocytes and mast cells, which are responsible for mediating allergic diseases, in conventional humanized mice. In this study, we developed a novel transgenic (Tg) strain, NOD/Shi-scid-IL2rgnull (NOG), bearing human IL-3 and GM-CSF genes (NOG IL-3/GM-Tg). In this strain, a large number of human myeloid cells of various lineages developed after transplantation of human CD34+ hematopoietic stem cells. Notably, mature basophils and mast cells expressing FcRI were markedly increased. These humanized NOG IL-3/GM-Tg mice developed passive cutaneous anaphylaxis reactions when administered anti-4-hydroxy-3- nitrophenylacetyl IgE Abs and 4-hydroxy-3-nitrophenylacetyl. More importantly, a combination of serum from Japanese cedar pollinosis patients and cedar pollen extract also elicited strong passive cutaneous anaphylaxis responses in mice. Thus, to our knowledge, our NOG IL-3/ GM-Tg mice are the first humanized mouse model to enable the study of human allergic responses in vivo and are excellent tools for preclinical studies of allergic diseases.",
author = "Ryoji Ito and Takeshi Takahashi and Ikumi Katano and Kenji Kawai and Tsutomu Kamisako and Tomoyuki Ogura and Miyuki Ida-Tanaka and Hiroshi Suemizu and Satoshi Nunomura and Chisei Ra and Akio Mori and Sadakazu Aiso and Mamoru Ito",
year = "2013",
month = "9",
day = "15",
doi = "10.4049/jimmunol.1203543",
language = "English",
volume = "191",
pages = "2890--2899",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "6",

}

TY - JOUR

T1 - Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice

AU - Ito, Ryoji

AU - Takahashi, Takeshi

AU - Katano, Ikumi

AU - Kawai, Kenji

AU - Kamisako, Tsutomu

AU - Ogura, Tomoyuki

AU - Ida-Tanaka, Miyuki

AU - Suemizu, Hiroshi

AU - Nunomura, Satoshi

AU - Ra, Chisei

AU - Mori, Akio

AU - Aiso, Sadakazu

AU - Ito, Mamoru

PY - 2013/9/15

Y1 - 2013/9/15

N2 - The development of animal models that mimic human allergic responses is crucial to study the pathophysiology of disease and to generate new therapeutic methodologies. Humanized mice reconstituted with human immune systems are essential to study human immune reactions in vivo and are expected to be useful for studying human allergies. However, application of this technology to the study of human allergies has been limited, largely because of the poor development of human myeloid cells, especially granulocytes and mast cells, which are responsible for mediating allergic diseases, in conventional humanized mice. In this study, we developed a novel transgenic (Tg) strain, NOD/Shi-scid-IL2rgnull (NOG), bearing human IL-3 and GM-CSF genes (NOG IL-3/GM-Tg). In this strain, a large number of human myeloid cells of various lineages developed after transplantation of human CD34+ hematopoietic stem cells. Notably, mature basophils and mast cells expressing FcRI were markedly increased. These humanized NOG IL-3/GM-Tg mice developed passive cutaneous anaphylaxis reactions when administered anti-4-hydroxy-3- nitrophenylacetyl IgE Abs and 4-hydroxy-3-nitrophenylacetyl. More importantly, a combination of serum from Japanese cedar pollinosis patients and cedar pollen extract also elicited strong passive cutaneous anaphylaxis responses in mice. Thus, to our knowledge, our NOG IL-3/ GM-Tg mice are the first humanized mouse model to enable the study of human allergic responses in vivo and are excellent tools for preclinical studies of allergic diseases.

AB - The development of animal models that mimic human allergic responses is crucial to study the pathophysiology of disease and to generate new therapeutic methodologies. Humanized mice reconstituted with human immune systems are essential to study human immune reactions in vivo and are expected to be useful for studying human allergies. However, application of this technology to the study of human allergies has been limited, largely because of the poor development of human myeloid cells, especially granulocytes and mast cells, which are responsible for mediating allergic diseases, in conventional humanized mice. In this study, we developed a novel transgenic (Tg) strain, NOD/Shi-scid-IL2rgnull (NOG), bearing human IL-3 and GM-CSF genes (NOG IL-3/GM-Tg). In this strain, a large number of human myeloid cells of various lineages developed after transplantation of human CD34+ hematopoietic stem cells. Notably, mature basophils and mast cells expressing FcRI were markedly increased. These humanized NOG IL-3/GM-Tg mice developed passive cutaneous anaphylaxis reactions when administered anti-4-hydroxy-3- nitrophenylacetyl IgE Abs and 4-hydroxy-3-nitrophenylacetyl. More importantly, a combination of serum from Japanese cedar pollinosis patients and cedar pollen extract also elicited strong passive cutaneous anaphylaxis responses in mice. Thus, to our knowledge, our NOG IL-3/ GM-Tg mice are the first humanized mouse model to enable the study of human allergic responses in vivo and are excellent tools for preclinical studies of allergic diseases.

UR - http://www.scopus.com/inward/record.url?scp=84884228760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884228760&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1203543

DO - 10.4049/jimmunol.1203543

M3 - Article

VL - 191

SP - 2890

EP - 2899

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 6

ER -